Evidence map›Paper›PMID 32669685›Full record

ReviewNature reviews. Neurology2020

Applications of machine learning to diagnosis and treatment of neurodegenerative diseases.

Monika A Myszczynska, Poojitha N Ojamies, Alix M B Lacoste, Daniel Neil, Amir Saffari, Richard Mead, Guillaume M Hautbergue, Joanna D Holbrook, Laura Ferraiuolo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 4 pooled it
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 4 syntheses or guidelines pooled it, 572 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. The role of "red flags" in the diagnostic work-up of hereditary transthyretin amyloidosis: a study using a machine-learning approach.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Monika A MyszczynskaSheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-0067-8500
Poojitha N OjamiesBenevolentAI, London, UK.
Alix M B LacosteBenevolentAI, Brooklyn, NY, USA.ORCID http://orcid.org/0000-0002-9353-6706
Daniel NeilBenevolentAI, London, UK.
Amir SaffariBenevolentAI, London, UK.
Richard MeadSheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-3207-0068
Guillaume M HautbergueSheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-1621-261X
Joanna D HolbrookBenevolentAI, London, UK.
Laura FerraiuoloSheffield Institute of Translational Neuroscience, University of Sheffield, Sheffield, UK. l.ferraiuolo@sheffield.ac.uk.ORCID http://orcid.org/0000-0001-9118-5714
BenevolentAI (United Kingdom) · GBUniversity of Sheffield · GB

Funding

Medical Research Council MR/R024162/1Motor Neurone Disease Association SITRAN/APR13/983-797
6 · The paper itself

Abstract

Globally, there is a huge unmet need for effective treatments for neurodegenerative diseases. The complexity of the molecular mechanisms underlying neuronal degeneration and the heterogeneity of the patient population present massive challenges to the development of early diagnostic tools and effective treatments for these diseases. Machine learning, a subfield of artificial intelligence, is enabling scientists, clinicians and patients to address some of these challenges. In this Review, we discuss how machine learning can aid early diagnosis and interpretation of medical images as well as the discovery and development of new therapies. A unifying theme of the different applications of machine learning is the integration of multiple high-dimensional sources of data, which all provide a different view on disease, and the automated derivation of actionable insights.

Indexed as

HumansMachine LearningNeurodegenerative DiseasesNeuroimaging

Identifiers

PMID32669685
OpenAlexW3043374725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.